Kojamo plc Stock Exchange Release, 30 October 2025 at 2.00 p.m. EET Kojamo plc’s Interim Report 1 January–30 September 2025 Occupancy rate improved, total revenue and net rental income increased This is a summary of the January–September Interim Report, which is in its entirety attached to this release and can be downloaded from the company’s website at www.kojamo.fi/investors. Unless otherwise stated, the comparison figures in brackets refer to the corresponding period of the previous year. The figures in this Interim Report have not been audited. Summary of July–September 2025Total revenue increased by 0.4 per cent to EUR 113.6 (113.2) million. Net rental income increased by 0.3 per cent totalling EUR 86.0 (85.7) million. Net rental income represented 75.7 (75.8) per cent of revenue. Result before taxes was EUR 32.8 (50.6) million....

MATTOON, Ill., Oct. 30, 2025 (GLOBE NEWSWIRE) — First Mid Bancshares, Inc. (NASDAQ: FMBH) (the “Company”) today announced its financial results for the quarter ended September 30, 2025. HighlightsQuarterly net income of $22.5 million, or $0.94 diluted EPS Adjusted quarterly net income* of $23.3 million, or $0.97 diluted EPS Net interest margin tax equivalent* expands to 3.80%, quarterly increase of 8 basis points, helping drive the sixth consecutive quarter of growth in net interest income Total loans of $5.82 billion, quarterly increase of $57.0 million, or 1.0% Total deposits of $6.29 billion, quarterly increase of $99.3 million, or 1.6% Tangible book value per share* increased 6.0% during the quarter to $28.21 Announced pending acquisition of Two Rivers Financial Group, Inc. Completion of core operating system conversion Completion...

ATLANTA, Oct. 30, 2025 (GLOBE NEWSWIRE) — Cumulus Media Inc. (OTCQB: CMLS) (the “Company,” “Cumulus Media,” “we,” “us,” or “our”) today announced operating results for the three and nine months ended September 30, 2025. Mary G. Berner, President and Chief Executive Officer of Cumulus Media, said, “In an advertising environment that remained challenging for legacy media, we continued to outperform. We once again gained market share in total broadcast spot as well as in digital, where our market share gains reflected the strong growth of our digital marketing services business, which was up 34% in the quarter. Additionally, we remained highly focused on re-engineering the business, reducing annualized fixed costs by $7 million and accelerating our efforts to implement...

STRASBURG, Va., Oct. 30, 2025 (GLOBE NEWSWIRE) — First National Corporation (the “Company” or “First National”) (NASDAQ: FXNC), the bank holding company of First Bank (the “Bank”), reported earnings for the quarter ended September 30, 2025, of $5.55 million and basic and diluted earnings per common share of $0.62.  “We are pleased to report another record quarter of financial performance as earnings improved over the prior quarter and the previous year, with earnings per share of $0.62 for the third quarter.  We closed the Touchstone acquisition one year ago and we are pleased with the results as we expand into these new markets. While loan growth remains muted due to higher-than-expected loan payoff volumes, we have recently added additional experienced bankers in our Richmond, Roanoke, and Staunton markets as we continue to build...

MONTREAL, Oct. 30, 2025 (GLOBE NEWSWIRE) — Knight Therapeutics Inc. (TSX: GUD) (“Knight”), a pan-American (ex-USA) specialty pharmaceutical company, will release its third quarter 2025 financial results on Thursday, November 6, 2025 prior to market opening. Following the release, Knight will hold a conference call and audio webcast. Knight cordially invites all interested parties to participate in this call. Date: Thursday, November 6, 2025 Time: 8:30 a.m. ET Telephone: Toll Free: 1-888-699-1199 or International 1-416-945-7677   Webcast: www.knighttx.com or WebcastThis is a listen-only audio webcast. Media Player is required to listen to the broadcast. Replay: An archived replay will be available for 30 days at www.knighttx.com. About Knight Therapeutics Inc. Knight Therapeutics Inc., headquartered in Montreal, Canada, is a specialty...

DETROIT, Oct. 30, 2025 (GLOBE NEWSWIRE) — DT Midstream, Inc. (NYSE: DTM) today announced third quarter 2025 reported net income of $115 million, or $1.13 per diluted share. For the third quarter of 2025, Operating Earnings were also $115 million, or $1.13 per diluted share. Adjusted EBITDA for the quarter was $288 million. Reconciliations of Operating Earnings and Adjusted EBITDA (non-GAAP measures) to reported net income are included at the end of this news release. The company also announced that the DT Midstream Board of Directors declared a $0.82 per share dividend on its common stock payable January 15, 2026 to stockholders of record at the close of business December 15, 2025. “We continue our strong performance in 2025,” said David Slater, President and CEO. “And we made great progress during the quarter on both the commercial...

Credit Trends Remain Solid Net Interest Margin Widening as Expected Declares Common and Preferred Dividends ENGLEWOOD CLIFFS, N.J., Oct. 30, 2025 (GLOBE NEWSWIRE) — ConnectOne Bancorp, Inc. (Nasdaq: CNOB) (the “Company” or “ConnectOne”), parent company of ConnectOne Bank (the “Bank”), today reported net income (loss) available to common stockholders of $39.5 million for the third quarter of 2025 compared with $(21.8) million for the second quarter of 2025 and $15.7 million for the third quarter of 2024. Diluted earnings (loss) per share were $0.78 for the third quarter of 2025 compared with $(0.52) for the second quarter of 2025 and $0.41 for the third quarter of 2024. On June 1, 2025, the merger with The First of Long Island Corporation (“FLIC”) was completed, thus operating results for the second quarter include one month of...

SANTIAGO, Chile, Oct. 30, 2025 (GLOBE NEWSWIRE) — Banco Santander Chile (NYSE: BSAC; SSE: Bsantander) announced today its results1 for the nine-month period ended September 30, 2025, and third quarter 2025 (3Q25). Solid financial performance with a ROAE2 of 24.0% in 9M253 As of September 30, 2025, the Bank’s net income attributable to shareholders totaled $798 billion ($4.23 per share and $1.76 per ADR), representing a 37.3% increase YoY4, with an ROAE of 24.0% in 9M25 compared to a ROAE of 18.2% in 9M245. The increase in results is explained by growth in the Bank’s main revenue lines. Operating income increased 14.8% YoY, driven by a better interest and readjustment margin and higher fees and results from financial transactions. Strong recovery of NIM6, reaching 4.0% in 9M25 Net interest income and readjustments (NII)...

BANNOCKBURN, Ill., Oct. 30, 2025 (GLOBE NEWSWIRE) — Option Care Health, Inc. (the “Company” or “Option Care Health”) (Nasdaq: OPCH), the nation’s largest independent provider of home and alternate site infusion services, announced today financial results for the third quarter ended September 30, 2025. Third Quarter 2025 Financial Highlights (Year-over-year comparisons unless otherwise noted)Net revenue of $1,435.0 million, up 12.2% Gross profit of $272.9 million, up 6.3% Net income of $51.8 million, down 3.8% GAAP diluted earnings per share of $0.32, up 3.2% Adjusted EBITDA of $119.5 million, up 3.4% Adjusted diluted earnings per share of $0.45, up 9.8% YTD cash provided by operating activities of $222.6 million Repurchased $62.5 million of stock in the quarter Term loan expanded $49.6 million, and interest rate reducedJohn...

Over 790,000 total VOQUEZNA® prescriptions filled to dateFilled VOQUEZNA prescriptions increased 28% from Q2 2025Net revenues of $49.5 million, up 25% quarter over quarter, and cash operating expenses down 43% quarter over quarterFull-year 2025 revenue guidance updated to $170–$175 million; company expects to achieve operating profitability in 2026Management to host conference call today, October 30, 2025, at 8:00 a.m. ETFLORHAM PARK, N.J., Oct. 30, 2025 (GLOBE NEWSWIRE) —  Phathom Pharmaceuticals, Inc. (Nasdaq: PHAT), a biopharmaceutical company focused on developing and commercializing novel treatments for gastrointestinal (GI) diseases, today reported financial results for the third quarter ended September 30, 2025, and provided a business update. “Our performance this quarter reinforces our belief in the strength...